SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-031670
Filing Date
2023-04-21
Accepted
2023-04-21 16:00:35
Documents
13
Period of Report
2023-03-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea177290-8ka1_somalogic.htm   iXBRL 8-K/A 33855
  Complete submission text file 0001213900-23-031670.txt   255072

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE slgc-20230324.xsd EX-101.SCH 4054
3 XBRL DEFINITION FILE slgc-20230324_def.xml EX-101.DEF 26737
4 XBRL LABEL FILE slgc-20230324_lab.xml EX-101.LAB 36934
5 XBRL PRESENTATION FILE slgc-20230324_pre.xml EX-101.PRE 25361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea177290-8ka1_somalogic_htm.xml XML 5802
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40090 | Film No.: 23836245
SIC: 8731 Services-Commercial Physical & Biological Research